Publications by authors named "C M Moorman"

Article Synopsis
  • Tolerogenic vaccines aim to create immune tolerance specifically for disease-related antigens, offering a safer alternative to broad immunosuppression, which can lead to infections and weakened anti-tumor responses.
  • They work by promoting certain immune cells that help regulate and suppress harmful immune responses, thus targeting conditions like autoimmunity and transplant rejection.
  • The design of these vaccines varies, often involving a relevant antigen paired with a tolerogenic adjuvant that enhances their effectiveness by creating a more favorable immune response through multiple mechanisms.
View Article and Find Full Text PDF

Conventional type 1 dendritic cells (DC1) contribute to the development of pathogenic T helper type 1 (Th1) cells in part the production of the proinflammatory cytokine interleukin-12. Thus, depletion of DC1 has the potential to dampen autoimmune responses. Here, we developed X-C motif chemokine receptor 1 (XCR1)-specific chimeric antigen receptor (CAR)-T cells and CAR-Tregs that specifically targeted DC1.

View Article and Find Full Text PDF

Background: Bicortical suspension device (BCSD) fixation treats proximal tibiofibular joint (PTFJ) instability in both the anterolateral and posteromedial directions. However, biomechanical data are lacking as to whether this technique restores the native stability and strength of the joint.

Purpose: To test (1) if BCSD fixation restores the native stability and strength and (2) if using 2 devices is needed.

View Article and Find Full Text PDF

Ungulate neonates-individuals less than four weeks old-typically experience the greatest predation rates, and variation in their survival can influence ungulate population dynamics. Typical methods to measure neonate survival involve capture and radio-tracking of adults and neonates to discover mortality events. This type of fieldwork is invasive and expensive, can bias results if it leads to neonate abandonment, and may still have high uncertainty about the predator species involved.

View Article and Find Full Text PDF

Chalcone isomerase-like (CHIL) protein is a noncatalytic protein that enhances flavonoid content in green plants by serving as a metabolite binder and a rectifier of chalcone synthase (CHS). Rectification of CHS catalysis occurs through direct protein-protein interactions between CHIL and CHS, which alter CHS kinetics and product profiles, favoring naringenin chalcone (NC) production. These discoveries raise questions about how CHIL proteins interact structurally with metabolites and how CHIL-ligand interactions affect interactions with CHS.

View Article and Find Full Text PDF